Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Modulation of Cardiac Metabolism by Beta-blockers: a role in apoptosis signaling

FY 2009-10

Summary
Beta-blockers are important medications used for treatment of heart problems that occur with diabetes. Our study will focus on two clinically relevant beta-blockers, metoprolol and carvedilol. Both drugs are known to interfere with signaling pathways in the body by binding cell surface beta-receptors, however, carvedilol has been shown to possess antioxidant properties as well. It is unclear if the antioxidant properties of carvedilol contribute to the improved effects seen with this drug. The focus of our study will be to compare the ability of metoprolol and carvedilol to improve problems seen in the diabetic rat heart, which include impaired heart function, changes in energy use and the amount of cell death. In addition, we plan to study the contribution of antioxidant effects by comparing carvedilol to metoprolol either alone or with the antioxidant, vitamin C.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201586
Name
Saran Varun
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Modulation of Cardiac Metabolism by Beta-blockers: a role in apoptosis signaling
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Beta Blockers; Cardiomyopathy; Carvedilol; Diabetes; Heart; Metabolism; Metoprolol; Oxidative Stress; Rat
Abstract
Beta-blockers are important medications used for treatment of heart problems that occur with diabetes. Our study will focus on two clinically relevant beta-blockers, metoprolol and carvedilol. Both drugs are known to interfere with signaling pathways in the body by binding cell surface beta-receptors, however, carvedilol has been shown to possess antioxidant properties as well. It is unclear if the antioxidant properties of carvedilol contribute to the improved effects seen with this drug. The focus of our study will be to compare the ability of metoprolol and carvedilol to improve problems seen in the diabetic rat heart, which include impaired heart function, changes in energy use and the amount of cell death. In addition, we plan to study the contribution of antioxidant effects by comparing carvedilol to metoprolol either alone or with the antioxidant, vitamin C.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saran, Varun
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~